Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.040 | 0.050 | 0.010 |
Shares | 99.310 | 99.310 | 0.000 |
Other | 0.640 | 0.640 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.075 | 14.611 |
Price to Book | 2.269 | 2.040 |
Price to Sales | 1.742 | 1.398 |
Price to Cash Flow | 10.708 | 9.256 |
Dividend Yield | 3.195 | 3.265 |
5 Years Earnings Growth | 9.940 | 9.813 |
Name | Net % | Category Average |
---|---|---|
Industrials | 18.190 | 15.936 |
Healthcare | 16.810 | 15.619 |
Financial Services | 16.800 | 17.502 |
Consumer Defensive | 10.690 | 11.296 |
Consumer Cyclical | 9.360 | 9.821 |
Technology | 8.270 | 9.599 |
Basic Materials | 6.700 | 6.687 |
Energy | 5.340 | 4.991 |
Communication Services | 3.760 | 5.041 |
Utilities | 3.430 | 4.617 |
Real Estate | 0.650 | 1.888 |
Number of long holdings: 200
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.25 | 832.4 | -2.07% | |
ASML Holding | NL0010273215 | 3.66 | 718.30 | +0.22% | |
AstraZeneca | GB0009895292 | 2.51 | 11,584.0 | -1.66% | |
Nestle | CH0038863350 | 2.44 | 82.88 | +1.02% | |
SAP | DE0007164600 | 2.29 | 206.850 | +1.15% | |
Novartis | CH0012005267 | 2.18 | 98.95 | -0.08% | |
Louis Vuitton | FR0000121014 | 2.02 | 595.10 | +0.54% | |
Shell | GB00BP6MXD84 | 2.01 | 31.16 | +1.17% | |
Roche Holding Participation | CH0012032048 | 1.71 | 268.80 | -0.15% | |
HSBC | GB0005405286 | 1.54 | 670.70 | +1.54% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0058496679 | 1.79B | 19.46 | 8.53 | 11.15 | ||
LU0553726919 | 335.27M | -2.20 | -15.40 | -1.25 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review